Development and evaluation of silver-impregnated amniotic membrane as an antimicrobial burn dressing

Journal of Burn Care and Research

Volumn 29, Issue 1, 2008, Pages 64-72

  Singh, Rita ^a   Kumar, Devendra ^a   Kumar, Pawan ^a   Chacharkar, Madhukar P ^a  

^a DEFENCE LABORATORY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

SILVER NITRATE;

AMNION; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COUNT; BACTERIUM CONTAMINATION; BURN; BURN DRESSING; CANDIDA ALBICANS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; IN VITRO STUDY; MOISTURE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SILVER IMPREGNATION; STAPHYLOCOCCUS AUREUS;

AMNION; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL DRESSINGS; BURNS; HUMANS; SILVER;

EID: 38049051826     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e31815f5a0f     Document Type: Article

References (27)

1. Sibbald RG. What is the bacterial burden of the wound bed and does it matter? In: Cherry GW, Harding KC, Ryan TJ, editors. Wound bed preparation. London: Royal Society of Medicine Press Ltd.; 2001. p. 41-6.
2. Kyriacou SV, Brownlow WJ, Xu XHN. Using nanoparticle optics assay for direct observation of the function of antimicrobial agents in single live bacterial cell. Biochemistry 2004;43:140-7.
3. Silver S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 2003;27:341-53.
4. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver Burns 2000;26:131-8.
5. Wright JB, Lam K, Olson ME, Burrell RE. Is antimicrobial efficacy sufficient? A question concerning the benefits of new dressings. Wounds 2003;15:133-42.
6. Brown-Etris M, Cutshall WD, Hiles MC. A new biomaterial derived from small intestine submucosa and developed into a wound matrix device. Wounds 2002;14:150-66.
7. Singh R, Chouhan US, Purohit S, et al. Radiation processed amniotic membranes in the treatment of non-healing ulcers of different etiology. Cell Tissue Banking 2004;5:129-34.
8. Robson MC, Krizek TJ. The effect of human amniotic membranes on the bacterial population of infected rat burns. Ann Surg 1973;177:144-9.
9. Phillips GO. Radiation technology in surgery and the pharmaceutical industry: an overview of applications. IAEA Bull 1994;36:19-23.
10. Singh R, Gupta P, Kumar P, Kumar A, Chacharkar MP. Properties of air dried radiation processed amniotic membranes under different storage conditions. Cell Tissue Banking 2003;4:95-100.
11. Branski LK, Jeschke MG, Kulp GA, Norbury WB, Herndon DN. Amnion in wound healing: different processing methods and irradiation influence the growth factor content of a biological dressing. J Burn Care Res 2007;28(Suppl 3):S84.
12. Thomas S, Loveless P. A comparative study of the properties of twelve hydrocolloid dressings. World Wide Wounds; July 1997; available from http://www.worldwidewounds.com/1997/july/Thomas-Hydronet/hydronet.html.
13. Matsumura Y, Yoshikata K, Kunisaki S, Tsuchido T. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol 2003;69:4278-81.
14. Lansdown AB. Silver I. Its antibacterial properties and mechanism of action. J Wound Care 2002;11:125-30.
15. Feng QL, Wu J, Chen GQ, Zhao K, Cui FZ, Kim TN. A mechanism study of antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2000;52:662-8.
16. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of Acticoat antimicrobial barrier dressing. J Burn Care Rehab 1999;20:195-200.
17. Fong J, Wood F, Fowler B. A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits. Burns 2005;31:562-7.
18. Caruso D, Foster KN, Blome-Eberwein SA, et al. Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns. J Burn Care Res 2006;27:298-309.
19. Ulkur E, Oncul O, Karagoz H, Yeniz E, Celikoz B. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci contaminated, full-skin thickness rat burn wounds. Burns 2005;31:874-7.
20. Haberal M, Oner Z, Bayraktar U, Bilgin N. The use of silver nitrate-incorporated membrane as a temporary dressing. Burns Therm Inj 1987;13:159-63.
21. Modak S, Fox P, Stanford J, Sampath L, Fox CL. Silver sulphadiazine-impregnated biological membranes as burn wound covers. J Burn Care Rehab 1986;7:422-5.
22. White RJ. An historical overview of the use of silver in wound management. Br J Nurs 2001;10(15 Suppl 2):S3-S8.
23. Leaper DJ. Silver dressings: their role in wound management. Int Wound J 2006;3:282-94.
24. Dunn K, Edwards-Jones V. The role of Acticoat with nanocrystalline silver in the management of burns. Burns 2004;30(Suppl):1-9.
25. Ovington LG. The truth about silver. Ostomy Wound Manage 2004;50(Suppl):1-10.
26. Wright JB, Hansen DL, Burrell RE. The comparative efficacy of two antimicrobial barrier dressings: in vitro examination of two controlled-release silver dressings. Wounds 1998;10:179-88.
27. Ip M, Lui SL, Poon VKM, Burd A. Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 2006;55:59-63.